Dr. Jessica M. Sun
Claim this profileDuke University Medical Center
Expert in Tumors
Expert in Brain Tumor
31 reported clinical trials
74 drugs studied
About Jessica M. Sun
Education:
- Earned an MD (Doctor of Medicine) from Duke University School of Medicine. The exact graduation year is not specified.
Experience:
- Participated in the 4th Year Electives program at Duke University Medical Center, as listed in the 2022-2023 Electives Book.
Area of expertise
1Tumors
Global LeaderStage IV
SMARCB1 positive
SMARCB1 negative
2Brain Tumor
Global LeaderStage IV
Stage I
Stage II
Affiliated Hospitals
Clinical Trials Jessica M. Sun is currently running
Genetic Testing-Directed Therapy
for Pediatric Cancer
This Pediatric MATCH screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing works in pediatric patients with solid tumors, non-Hodgkin lymphomas, or histiocytic disorders that have progressed following at least one line of standard systemic therapy and/or for which no standard treatment exists that has been shown to prolong survival. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with genetic changes or abnormalities (mutations) may benefit more from treatment which targets their tumor's particular genetic mutation, and may help doctors plan better treatment for patients with solid tumors or non-Hodgkin lymphomas.
Recruiting1 award Phase 214 criteria
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
More about Jessica M. Sun
Clinical Trial Related7 years of experience running clinical trials · Led 31 trials as a Principal Investigator · 19 Active Clinical TrialsTreatments Jessica M. Sun has experience with
- Cyclophosphamide
- Etoposide
- Methotrexate
- Doxorubicin Hydrochloride
- Vincristine Sulfate
- Inotuzumab Ozogamicin
Breakdown of trials Jessica M. Sun has run
Tumors
Brain Tumor
Neuroblastoma
Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jessica M. Sun specialize in?
Jessica M. Sun focuses on Tumors and Brain Tumor. In particular, much of their work with Tumors has involved Stage IV patients, or patients who are SMARCB1 positive.
Is Jessica M. Sun currently recruiting for clinical trials?
Yes, Jessica M. Sun is currently recruiting for 18 clinical trials in Durham North Carolina. If you're interested in participating, you should apply.
Are there any treatments that Jessica M. Sun has studied deeply?
Yes, Jessica M. Sun has studied treatments such as Cyclophosphamide, Etoposide, Methotrexate.
What is the best way to schedule an appointment with Jessica M. Sun?
Apply for one of the trials that Jessica M. Sun is conducting.
What is the office address of Jessica M. Sun?
The office of Jessica M. Sun is located at: Duke University Medical Center, Durham, North Carolina 27710 United States. This is the address for their practice at the Duke University Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.